The stock was in corrective mode while all other pharma names were making new highs. It gave good Q1 results. 2 new plants are getting operational soon which should provide operational leverage. Very positive for long term. In terms of technicals, it gave strong BO from its falling trend channel and is now making higher highs. With the RSI also trending higher, the stock should reach ATH soon. Plan to add more in coming days.